These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17277230)

  • 1. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
    Li J; Sejas DP; Burma S; Chen DJ; Pang Q
    Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
    Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
    J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATM/p53/p21 pathway influences cell fate decision between apoptosis and senescence in reoxygenated hematopoietic progenitor cells.
    Zhang X; Li J; Sejas DP; Pang Q
    J Biol Chem; 2005 May; 280(20):19635-40. PubMed ID: 15753076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
    Mallette FA; Gaumont-Leclerc MF; Ferbeyre G
    Genes Dev; 2007 Jan; 21(1):43-8. PubMed ID: 17210786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-Independent apoptosis disrupts early organogenesis in embryos lacking both ataxia-telangiectasia mutated and Prkdc.
    Gladdy RA; Nutter LM; Kunath T; Danska JS; Guidos CJ
    Mol Cancer Res; 2006 May; 4(5):311-8. PubMed ID: 16687486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
    Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
    Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.
    Gilad O; Nabet BY; Ragland RL; Schoppy DW; Smith KD; Durham AC; Brown EJ
    Cancer Res; 2010 Dec; 70(23):9693-702. PubMed ID: 21098704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.
    Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW
    Blood; 2003 Dec; 102(12):4146-52. PubMed ID: 12855557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.
    Shen KC; Heng H; Wang Y; Lu S; Liu G; Deng CX; Brooks SC; Wang YA
    Cancer Res; 2005 Oct; 65(19):8747-53. PubMed ID: 16204044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells.
    Kinoshita T; Nagamatsu G; Kosaka T; Takubo K; Hotta A; Ellis J; Suda T
    Biochem Biophys Res Commun; 2011 Apr; 407(2):321-6. PubMed ID: 21385566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.
    Zhang X; Sejas DP; Qiu Y; Williams DA; Pang Q
    J Cell Sci; 2007 May; 120(Pt 9):1572-83. PubMed ID: 17405815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: role in β-adrenergic receptor-stimulated apoptosis.
    Foster CR; Zha Q; Daniel LL; Singh M; Singh K
    Exp Physiol; 2012 Apr; 97(4):506-15. PubMed ID: 22179422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM is activated by mitotic stress and suppresses centrosome amplification in primary but not in tumor cells.
    Shen K; Wang Y; Brooks SC; Raz A; Wang YA
    J Cell Biochem; 2006 Dec; 99(5):1267-74. PubMed ID: 16775842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70.
    Yamaguchi S; Hasegawa M; Aizawa S; Tanaka K; Yoshida K; Noda Y; Tatsumi K; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Mar; 29(3):307-16. PubMed ID: 15661267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM-deficient human fibroblast cells are resistant to low levels of DNA double-strand break induced apoptosis and subsequently undergo drug-induced premature senescence.
    Park J; Jo YH; Cho CH; Choe W; Kang I; Baik HH; Yoon KS
    Biochem Biophys Res Commun; 2013 Jan; 430(1):429-35. PubMed ID: 23178571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
    Li J; Zhang X; Sejas DP; Pang Q
    Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.
    Efeyan A; Murga M; Martinez-Pastor B; Ortega-Molina A; Soria R; Collado M; Fernandez-Capetillo O; Serrano M
    PLoS One; 2009; 4(5):e5475. PubMed ID: 19421407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined haploinsufficiency for ATM and RAD9 as a factor in cell transformation, apoptosis, and DNA lesion repair dynamics.
    Smilenov LB; Lieberman HB; Mitchell SA; Baker RA; Hopkins KM; Hall EJ
    Cancer Res; 2005 Feb; 65(3):933-8. PubMed ID: 15705893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.